Pharmaceuticals

Pharmaceuticals accounts for 54 insolvency cases on record since 2017. Of the concluded cases, 22 ended in an approved resolution plan and 14 in liquidation — a liquidation rate of 38.9%. 15 remain under CIRP today. Cases here take a median 477 days from admission to a plan or liquidation order (n=36), against a national median of 480 days (n=4,663).

Median haircut not shown — only 22 approved plans here carry a figure, below the 30-case base we require before publishing a benchmark.

Figures, haircuts and benchmarks sit on each case page, for members. This index is the public record; the interpretation is the product.

Sourced exclusively from public record — IBBI publications and announcements, NCLT and NCLAT orders. Every figure stored verbatim; a blank means not yet filed, never zero. Data as of 2026-09-25. Read the methodology · Browse A–Z · by sector · by bench · bench duration intelligence.